Health Care Equipment & Services

Fresenius Medical Care’s new 5‑year bond, issued after divesting a dialysis arm, shows a solid 3%+ coupon, 4%+ yield, and a 2.6× EBITDA ratio that keeps the company in the lower‑tier investment‑grade zone while boosting profits and growth prospects.

Medline Industries strengthens its N95 respirator leadership with robust supply chains, strict U.S. compliance, and a focus on quality—positioning it to meet growing global demand.

Explore how Fresenius’s China restructuring boosts European healthcare efficiency, aligns with value‑based reimbursement, and drives tech‑driven cost savings.

European equity markets end the week on a modest uptick driven by falling oil prices, with UBS’s banking boost and EssilorLuxottica’s governance dispute shaping the highlights.

Medline Industries dominates the N95 respirator market, offering proven safety, high filtration, and robust compliance to meet evolving PPE demands worldwide.

Centene Corp tackles shrinking ACA enrollments and AI coding costs—learning to adjust pricing, invest in tech, and safeguard quality to stay profitable in a shifting health‑insurance landscape.

UnitedHealth Group shares climb, buoyed by its broad health‑insurance portfolio and steady shareholder activity, showing resilience amid market volatility and evolving ACA plans.

Fresenius Medical Care pivots China strategy: exits low‑margin 4008A & peritoneal dialysis, doubles in‑center HDF and critical‑care tech, boosting margins and patient outcomes.

Short‑selling of Siemens Healthineers reveals investor concern amid AI, cloud, and value‑based reimbursement shifts—discover how the company’s strategy and cost dynamics shape its future.

Fresenius SE & Co. KGaA’s 0.5% short‑position filing is a routine regulatory update—no impact on products, pricing or patient care.